← Leaderboards
Wayn M Koch
Johns Hopkins University
$6,667,862
Attributed
$6,667,862
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $770.5K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$6,667,862 · 3
By mechanism
R01$4,988,030 · 1
P50$1,679,832 · 2
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- David Sidransky$59,922,938
- Dorry Segev$40,743,790
- Christine Marie Durand$23,429,807
- Cynthia L Sears$16,773,568
- Maura L Gillison$5,649,784
Others in their field
Top investigators on “Early Diagnosis”
- Michael W Weiner · Northern California Institute Res &Educ$162,576,753
- Mitchell D Schnall · University Of Pennsylvania$148,421,012
- David Heimbrook · Leidos Biomedical Research, Inc.$98,656,722
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$85,695,840
- Sharon A Nachman · Johns Hopkins University$77,262,665
- Peter J O'Dwyer · University Of Pennsylvania$75,791,391
Research focus
Early DiagnosisEvaluationPilot ProjectsTumorRecurrenceCellsTissuesSpecimenHead And Neck Squamous Cell CarcinomaHypermethylationMolecularMethylationSensitivity And SpecificityPromotor (Genetics)CohortDetectionSamplingMucous MembraneSerumBaseCharacteristicsPromoter Regions (Genetics)SalivaGene Mutation
Grant awards (19)
Biomarkers for Margin Analysis and Prognosis in HNSCC$386,830
R01 · FY2013 · DE · contact PI
Biomarkers for Margin Analysis and Prognosis in HNSCC$402,929
R01 · FY2012 · DE · contact PI
Biomarkers for Margin Analysis and Prognosis in HNSCC$394,770
R01 · FY2011 · DE · contact PI
MOLECULAR SCREENING AND RISK PREDICTION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA$339,102
P50 · FY2011 · DE · contact PI
Biomarkers for Margin Analysis and Prognosis in HNSCC$406,962
R01 · FY2010 · DE · contact PI
MOLECULAR SCREENING AND RISK PREDICTION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA$351,586
P50 · FY2010 · DE · contact PI
Biomarkers for Margin Analysis and Prognosis in HNSCC$427,054
R01 · FY2009 · DE · contact PI
MOLECULAR SCREENING AND RISK PREDICTION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA$343,415
P50 · FY2009 · DE · contact PI
MOLECULAR SCREENING AND RISK PREDICTION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA$336,791
P50 · FY2008 · DE · contact PI
Biomarkers for margin analysis and prognosis in HNSCC$358,467
R01 · FY2007 · DE · contact PI
MOLECULAR SCREENING AND RISK PREDICTION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA$308,938
P50 · FY2007 · DE · contact PI
Biomarkers for margin analysis and prognosis in HNSCC$369,762
R01 · FY2006 · DE · contact PI
Biomarkers for margin analysis and prognosis in HNSCC$386,090
R01 · FY2005 · DE
Biomarkers for margin analysis and prognosis in HNSCC$388,313
R01 · FY2004 · DE
GENETIC ALTERATIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARK$378,970
R01 · FY2003 · DE
GENETIC ALTERATIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARK$370,486
R01 · FY2002 · DE
Molecular Screening &Risk Prediction of Head &Neck SCC$0
P50 · FY2002 · CA
GENETIC ALTERATIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARK$362,247
R01 · FY2001 · DE
GENETIC ALTERATIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARK$355,150
R01 · FY2000 · DE